Cover Image
市場調查報告書

飼料用Eubiotics成分的世界市場趨勢、預測 ∼2020年:各類型 (益生菌、益生元、有機酸、精油)、家畜、地區

Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, & Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, & Aquaculture), & by Region (North America, Europe, Asia-Pacific, & Rest of the World) - Global Trends & Forecast to 2020

出版商 MarketsandMarkets 商品編碼 298905
出版日期 內容資訊 英文 173 Pages
訂單完成後即時交付
價格
Back to Top
飼料用Eubiotics成分的世界市場趨勢、預測 ∼2020年:各類型 (益生菌、益生元、有機酸、精油)、家畜、地區 Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, & Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, & Aquaculture), & by Region (North America, Europe, Asia-Pacific, & Rest of the World) - Global Trends & Forecast to 2020
出版日期: 2015年08月28日 內容資訊: 英文 173 Pages
簡介

飼料用Eubiotics成分的市場近幾年急劇成長。今後也預計從2015年到2020年以7.4%的年複合成長率發展,從2014年的46億2000萬美元,2020年成長到70億5000美萬美元的規模。

本報告提供全球飼料用Eubiotics成分的市場相關調查、Eubiotics成分種類與概要、產業結構與價值鏈、各成分、家畜種類的市場趨勢及市場規模的變化與預測、地區及主要國家的趨勢、市場成長的各種影響因素分析、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 富有魅力的市場機會
  • 益生菌:主要的類型
  • Eubiotics的主要市場
  • 歐洲:最大的地區市場
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
    • Eubiotics成分的各種類型
      • 益生菌
      • 益生元
      • 精油
      • 有機酸
  • 市場區隔
    • 各類型
    • 各家畜
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題
  • 法律規章
    • 飼料添加物的抗生素
    • 抗生素的禁止
      • 歐洲
      • 韓國
      • 美國

第6章 產業趨勢

  • 簡介
  • 價值鏈分析
  • 供應鏈分析
  • 波特的五力分析
  • 策略性基準
    • 擴張、投資

第7章 各類型市場

  • 簡介
  • 益生菌
    • 乳酸菌
    • 雙桿菌
  • 益生元
    • 菊糖
    • 寡果醣 (FOS)
    • 半乳寡糖 (GOS)
  • 精油
  • 有機酸

第8章 各家畜市場

  • 簡介
  • 反芻動物
  • 水棲動物
  • 其他

第9章 各地區市場

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 瑞士
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 其他
  • 其他
    • 巴西
    • 阿根廷
    • 南非
    • 其他

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 擴張、投資
    • M&A
    • 協定、聯盟、合資企業、聯盟
    • 新產品的投入
    • 技術創新

第11章 企業簡介

  • 簡介
  • CHR. HANSEN A/S
  • ROYAL DSM
  • E. I. DU PONT DE NEMOURS AND COMPANY
  • CARGILL INCORPORATED
  • KEMIN INDUSTRIES INC.
  • BASF SE
  • BEHN MEYER GROUP
  • BENEO GROUP
  • NOVUS INTERNATIONAL, INC.
  • ADDCON
    • 企業概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 近幾年的發展趨勢等

第12章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: AGI 2342

The eubiotics market in feed has been growing rapidly in the recent years and is projected to reach a market size at USD 7.05 billion by 2020. The market is primarily driven by the growing customer attention towards superior quality feed grades, ban on antibiotics used as growth promoters in the North American and European regions, and for feed supplementation to improve nutrient utilization and nutrient supply to the animals. The consumption of eubiotics is increasing significantly due to various government regulations being adopted to improve animal health.

Europe held the largest share of the eubiotics market in 2014. Currently, the eubiotics market is concentrated more in developed and developing countries, such as U.S., China, India, Japan, Australia, along with European countries. The growth is mainly due to the global increase in meat consumption and rise in concern regarding its quality and safety. The market for probiotics is projected to grow at the highest CAGR of 7.6% during the period from 2015 to 2020. The probiotics segment also accounted for the largest share of 65.47% in 2014, and is projected to be valued at USD 4.69 billion by 2020.

The eubiotics market is highly competitive with a large number of global market players. This report highlights the growth strategies adopted by the major market players between 2010 and 2015. Key industry players invest extensively in research and development initiatives to expand their product portfolios. Continuous investments in new product development, launches, and expansions have expanded the scope of the industry.

The global market is marked with intense competition due to the presence of a large number of big and small firms. New product developments, mergers & acquisitions, and expansions are the key strategies adopted by market players to ensure their growth. The market is dominated by players such as the Chr. Hansen (Denmark), Cargill Incorporated (U.S.) and ADDCON (Germany), BASF SE (Germany), Kemin Industries Inc. (U.S.), and Behn Meyer (Singapore).

In this report, the global eubiotics market is segmented into type, livestock, and region. The said market was valued at USD 4.62 billion in 2014 and is projected to grow at a CAGR of 7.4% from 2015 to 2020.

AVAILABLE CUSTOMIZATIONS

With the given market data, MarketsandMarkets offers customizations according to the company's specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product matrix which gives a detailed comparison of product portfolio of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific eubiotics market into Malaysia, Thailand, Indonesia, and Vietnam
  • Further breakdown of the Rest of RoW eubiotics market into Argentina, Madagascar, Morocco, Chile, Peru, and Sudan

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. YEARS CONSIDERED
  • 1.4. CURRENCY CONSIDERED
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key Data from Secondary Sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data from Primary Sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of Primary Interviews
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Growing population and rising diversified food demand
      • 2.2.2.2. Emerging Economies: Population & Meat Demand
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Parent Market Analysis: Animal Feed Industry
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.5.1. ASSUMPTIONS
    • 2.5.2. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN EUBIOTICS MARKET
  • 4.2. PROBIOTICS: LEADING SEGMENT BY TYPE
  • 4.3. LEADING MARKET FOR EUBIOTICS
  • 4.4. EUROPE: LARGEST EUBIOTICS MARKET
  • 4.5. LIFE CYCLE ANALYSIS: BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DIFFERENT TYPES OF EUBIOTICS
      • 5.1.1.1. Probiotics
      • 5.1.1.2. Prebiotics
      • 5.1.1.3. Essential oils
      • 5.1.1.4. Organic acids
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. EUBIOTICS MARKET, BY TYPE
    • 5.2.2. EUBIOTICS MARKET, BY LIVESTOCK
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increase in meat production/consumption
      • 5.3.1.2. Rising awareness about feed quality
      • 5.3.1.3. Increasing disease outbreaks in livestock
      • 5.3.1.4. Replacing antibiotic growth promoters (AGP) with eubiotics in feed
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Regulatory structure & intervention
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Investment in research & development
      • 5.3.3.2. Exploring regional & untapped markets
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Rise in Raw Material Prices
  • 5.4. REGULATIONS
    • 5.4.1. ANTIBITOTICS AS FEED ADDITIVES
    • 5.4.2. BAN ON ANTIBIOTICS
      • 5.4.2.1. Europe
      • 5.4.2.2. South Korea
      • 5.4.2.3. U.S.

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. SUPPLY CHAIN ANALYSIS
    • 6.3.1. PROMINENT COMPANIES
    • 6.3.2. SMALL & MEDIUM ENTERPRISES
    • 6.3.3. END USERS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. INTENSITY OF COMPETITIVE RIVALRY
    • 6.4.2. BARGAINING POWER OF SUPPLIERS
    • 6.4.3. BARGAINING POWER OF BUYERS
    • 6.4.4. THREAT OF NEW ENTRANTS
    • 6.4.5. THREAT OF SUBSTITUTES
  • 6.5. STRATEGIC BENCHMARKING
    • 6.5.1. EXPANSIONS & INVESTMENTS

7. EUBIOTICS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. PROBIOTICS
    • 7.2.1. LACTOBACILLI
    • 7.2.2. BIFIDOBACTERIA
  • 7.3. PREBIOTICS
    • 7.3.1. INULIN
    • 7.3.2. FRUCTOOLIGOSACCHARIDES (FOS)
    • 7.3.3. GALACTO-OLIGOSACCHARIDES (GOS)
  • 7.4. ESSENTIAL OILS
  • 7.5. ORGANIC ACIDS

8. EUBIOTICS MARKET, BY LIVESTOCK

  • 8.1. INTRODUCTION
    • 8.1.1. KEY FEATURES
      • 8.1.1.1. Modulation of microflora
      • 8.1.1.2. Stimulate the immune response
      • 8.1.1.3. Metabolite excretion
  • 8.2. SWINE
    • 8.2.1. KEY FEATURES
      • 8.2.1.1. Prevent, Stimulate, and Neutralize
      • 8.2.1.2. Defence against infection
  • 8.3. POULTRY
    • 8.3.1. KEY FEATURES
      • 8.3.1.1. Growth and improved feed conversion rate
  • 8.4. RUMINANTS
  • 8.5. AQUATIC ANIMALS
  • 8.6. EUBIOTICS FOR OTHER LIVESTOCK TYPES

9. EUBIOTICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
    • 9.2.3. MEXICO
  • 9.3. EUROPE
    • 9.3.1. U.K.
    • 9.3.2. GERMANY
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. RUSSIA
    • 9.3.7. SWITZERLAND
    • 9.3.8. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. JAPAN
    • 9.4.4. AUSTRALIA
    • 9.4.5. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. BRAZIL
    • 9.5.2. ARGENTINA
    • 9.5.3. SOUTH AFRICA
    • 9.5.4. OTHER COUNTRIES IN ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. EUBIOTICS MARKET: MARKET SHARE ANALYSIS (DEVELOPMENTS)
  • 10.3. COMPETITIVE SITUATIONS & TRENDS
    • 10.3.1. EXPANSIONS & INVESTMENTS
    • 10.3.2. MERGERS & ACQUISITIONS
    • 10.3.3. AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS
    • 10.3.4. NEW PRODUCT LAUNCHES
    • 10.3.5. INNOVATION

11. COMPANY PROFILES (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

  • 11.1. INTRODUCTION
  • 11.2. CHR. HANSEN A/S
  • 11.3. ROYAL DSM
  • 11.4. E. I. DU PONT DE NEMOURS AND COMPANY
  • 11.5. CARGILL INCORPORATED
  • 11.6. KEMIN INDUSTRIES INC.
  • 11.7. BASF SE
  • 11.8. BEHN MEYER GROUP
  • 11.9. BENEO GROUP
  • 11.10. NOVUS INTERNATIONAL, INC.
  • 11.11. ADDCON

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. COMPANY DEVELOPMENTS
    • 12.3.1. NEW PRODUCT LAUNCHES/DEVELOPMENTS
    • 12.3.2. MERGERS & ACQUISITIONS
    • 12.3.3. EXPANSIONS & INVESTMENTS
  • 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PER CAPITA CONSUMPTION OF MEAT
  • TABLE 2: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 3: PROBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: PREBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: ESSENTIAL OILS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: ORGANIC ACIDS MARKET SIZE, BY REGION,2013-2020 (USD MILLION)
  • TABLE 7: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL MEAT PRODUCTION MARKET SIZE, BY MEAT TYPE, 2013-2020 (KT)
  • TABLE 9: PER CAPITA PORK CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020 (KG/YEAR)
  • TABLE 10: SWINE: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: PER CAPITA POULTRY CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020(KG/YEAR)
  • TABLE 12: POULTRY: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: PER CAPITA BEEF CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020 (KG/YEAR)
  • TABLE 14: RUMINANTS: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: PER CAPITA FISH CONSUMPTION, BY KEY COUNTRY, 2013-2014 (KG/YEAR)
  • TABLE 16: AQUATIC ANIMALS: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: OTHER LIVESTOCK EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 22: U.S.: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 23: U.S.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 24: CANADA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: CANADA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 26: MEXICO: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 27: MEXICO: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 28: EUROPE: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 31: U.K.: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: U.K.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 33: GERMANY: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: GERMANY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 35: FRANCE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: FRANCE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 37: ITALY: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: ITALY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 39: SPAIN: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: SPAIN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 41: RUSSIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: RUSSIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 43: SWITZERLAND: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: SWITZERLAND: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 45: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 47: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 50: CHINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: CHINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 52: INDIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: INDIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 54: JAPAN: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: JAPAN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 56: AUSTRALIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: AUSTRALIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 58: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 60: ROW: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 63: BRAZIL: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: BRAZIL: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 65: ARGENTINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ARGENTINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 67: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 69: OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 71: EXPANSIONS & INVESTMENTS, 2010-2015
  • TABLE 72: MERGERS & ACQUISITIONS, 2010-2015
  • TABLE 73: AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS, 2010-2015
  • TABLE 74: NEW PRODUCT LAUNCHES, 2010-2015
  • TABLE 75: BASF SE: PRODUCTS & THEIR DESCRIPTION

LIST OF FIGURES

  • FIGURE 1: EUBIOTICSMARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: POPULATION GROWTH TREND, 1961-2050
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: EUBIOTICS MARKET SNAPSHOT, BY LIVESTOCK (2015 VS. 2020)
  • FIGURE 8: EUBIOTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • FIGURE 9: EUBIOTICS MARKET SIZE, BY TYPE, 2015-2020 USD (USD MILLION)
  • FIGURE 10: EUBIOTICS MARKET SHARE (VALUE), BY REGION, 2014
  • FIGURE 11: GROWTH IN EUBIOTICS MARKET
  • FIGURE 12: PROBIOTICS PROJECTED TO BE THE LARGEST SEGMENT
  • FIGURE 13: U.S.: LARGEST MARKET FOR EUBIOTICS (2015-2020)
  • FIGURE 14: PROBIOTICS SEGMENT ACCOUNTED FOR LARGEST SHARE IN THE EUROPEAN EUBIOTICS MARKET, 2014
  • FIGURE 15: ASIA-PACIFIC REGION TO PROVIDE IMMENSE POTENTIAL OPPORTUNITIES FOR EUBIOTICS MARKET GROWTH
  • FIGURE 16: EUBIOTICS MARKET, BY TYPE
  • FIGURE 17: EUBIOTICS MARKET, BY LIVESTOCK
  • FIGURE 18: INCREASE IN MEAT PRODUCTION/CONSUMPTION DRIVING THE GROWTH OF EUBIOTICS MARKET
  • FIGURE 19: R&D CONTRIBUTES MAJOR VALUE TO OVERALL PRICE OF EUBIOTICS MARKET
  • FIGURE 20: RESEARCH ORGANIZATIONS & TECHNOLOGISTS: INTEGRAL PART OF SUPPLY CHAIN OF EUBIOTICS MARKET
  • FIGURE 21: PORTER'S FIVE FORCES ANALYSIS: EUBIOTICS MARKET
  • FIGURE 22: STRATEGIC BENCHMARKING: EXPANSIONS & INVESTMENTS
  • FIGURE 23: PROBIOTICS IS THE FASTEST GROWING SEGMENT IN EUBIOTICS MARKET
  • FIGURE 24: EUROPE IS PROJECTED TO LEAD THE PREBIOTICS MARKET IN 2020
  • FIGURE 25: EUBIOTICS MARKET SHARE (VALUE), BY LIVESTOCK, 2015-2020
  • FIGURE 26: GEOGRAPHIC SNAPSHOT (2015-2020): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOTSPOTS
  • FIGURE 27: NORTH AMERICAN EUBIOTICS MARKET: A SNAPSHOT, 2014
  • FIGURE 28: EUROPEAN EUBIOTICS MARKET: A SNAPSHOT, 2014
  • FIGURE 29: CHINA WAS THE MARKET LEADER IN THE ASIA-PACIFIC REGION IN 2014
  • FIGURE 30: EXPANSIONS AND INVESTMENTS: LEADING APPROACH OF KEY PLAYERS
  • FIGURE 31: EUBIOTICS MARKET SHARE (DEVELOPMENTS), BY COMPANY, 2010-2015
  • FIGURE 32: EXPANSIONS, INVESTMENTS, FUELED GROWTH OF EUBIOTICS MARKET BETWEEN 2010 TO 2015
  • FIGURE 33: EXPANSIONS AND INVESTMENTS: THE KEY STRATEGY, 2010-2015
  • FIGURE 34: GEOGRAPHICAL REVENUE MIX OF TOP 5 MARKET PLAYERS
  • FIGURE 35: CHR. HANSEN A/S: COMPANY SNAPSHOT
  • FIGURE 36: CHR. HANSEN A/S: SWOT ANALYSIS
  • FIGURE 37: ROYAL DSM : COMPANY SNAPSHOT
  • FIGURE 38: DSM N. V.: SWOT ANALYSIS
  • FIGURE 39: E. I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 40: E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS
  • FIGURE 41: CARGILL INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 42: CARGILL INCORPORATED: SWOT ANALYSIS
  • FIGURE 43: KEMIN INDUSTRIES INC.: SWOT ANALYSIS
  • FIGURE 44: BASF SE: COMPANY SNAPSHOT
  • FIGURE 45: BASF SE: SWOT ANALYSIS
Back to Top